NLS

Denmark - December 15, 2025

Japanese quantum startup choses Copenhagen for European headquarters

The Japanese start-up QunaSys has chose to locate their European headquarters in Innovation District Copenhagen, in the start-up community Quantum Denmark.

Acquisition - December 14, 2025

Sobi to acquire Arthrosi Therapeutics

Sobi will pay USD 950 million upfront in cash to acquire Arthrosi, together with up to USD 550 million in cash in clinical, regulatory and sales milestones.

In a new job - December 11, 2025

NMD Pharma appoints Chief Medical Officer

NMD Pharma has announced the appointment of Ana de Vera as Chief Medical Officer (CMO), effective immediately.

Clinical Trials - December 11, 2025

Muna Therapeutics doses first subjects in Phase 1 trial

It is a phase 1 single-ascending dose/multiple-ascending dose study of lead asset MNA-001 in healthy adult participants.

In a new job - December 11, 2025

OssDsign appoints new CEO

The company has appointed Mark Waugh as CEO, effective 1st January 2026.

Agreement - December 11, 2025

Nanexa and Moderna enter into license and option agreement

Nanexa will receive an upfront payment of USD 3 million and is entitled to up to USD 500 million in potential milestone payments as well as a tiered single-digit royalty on product sales.

Sign up to our Newsletter!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.